D154ATG Entrust AT
Implantable Cardioverter Defibrillator (ICD)
D154ATG Entrust AT

Device Survival Probability


    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr at 100.0 mo                        
% Excluding Normal Battery Depletion 100.0 99.9 99.8 99.6 99.4 99.4 99.3 99.3 99.3                        
% Including Normal Battery Depletion 99.2 98.9 98.3 96.9 89.6 69.4 35.9 6.4 1.6                        
#   24758 22548 20183 17741 14622 10455 4861 734 183                        
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.

Product Characteristics

Generator Type ICD
Max. Delivered Energy 35 J
Connector Style DR Style
Serial Number Prefix PNR
Mass 68g
Volume 35cc
Waveform Biphasic
Hide this content
DR Style

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 3.8 4.2 4.4 4.6
Quarterly 5.5 6.1 6.8 7.0
Semi-annual 6.1 7.0 7.9 8.3

Longevity estimates based on the following device usage. Pacing Mode DDD; Atrial Lower Pacing Rate 60ppm; Ventricular Lower Pacing Rate 60ppm; Atrial Pulse Width 0.4ms; Ventricular Pulse Width 0.4ms; Atrial Pulse Amplitude 3V; Ventricular Pulse Amplitude 3V; Atrial Impedance 510ohms; Ventricle Impedance 510ohms; Atrial Sensing Rate 70bpm; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Atrial Fib percentage of time 0%; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content


Distribution Data

US Market Release2005-06-30
CE Approval Date2005-02-04
Registered USA Implants28091
Estimated Active USA Implants904
Normal Battery Depletions8745
US Market Release2005-06-30
CE Approval Date2005-02-04
Estimated WW Distribution37716
Normal Battery Depletions9375

Malfunctions (USA)

Therapy Function Not Compromised 109
Electrical Component 30
Electrical Interconnect 1
Possible Early Battery Depletion 74
Software/Firmware 3
Other 1
Therapy Function Compromised 16
Electrical Component 16

Malfunctions (WW)

Therapy Function Not Compromised 176
Electrical Component 75
Electrical Interconnect 3
Possible Early Battery Depletion 92
Software/Firmware 4
Other 2
Therapy Function Compromised 23
Battery 2
Electrical Component 21

EOS Indication

EOL device status is defined as three months following an ERI indication assuming the following post-ERI conditions: 100% DDD pacing at 60 min-1, 2.5 V, 0.4 ms; 500 Ohm pacing load; and six full-energy charges. EOL may be indicated before the end of three months if the device exceeds these conditions.


Recommended Replacement (RRT)

Battery voltage less than or equal to 2.61V.


Charge Time


Data as of November 8, 2019

www.medtronic.com/productperformance 726050